comparemela.com

Latest Breaking News On - Post hoc cohort analysis - Page 1 : comparemela.com

AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD

THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a key driver of mortality, in COPD First patients dosed in.

United-states
Japan
New-york
China
Netherlands
Smeeth
Kent
United-kingdom
Cambridge
Cambridgeshire
Americans
Fernando-martinez

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.